triptolide has been researched along with Epithelial Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Feng, Y; Hu, H; Huang, G; Li, X; Tan, B; Wang, H; Wang, X | 1 |
| Geller, M; Ramakrishnan, S; Rivard, C; Saluja, A; Saluja, M; Schnettler, E; Vogel, RI | 1 |
| Ikegawa, M; Kamoto, T; Matsui, Y; Nishiyama, H; Ogawa, O; Watanabe, J | 1 |
3 other study(ies) available for triptolide and Epithelial Neoplasms
| Article | Year |
|---|---|
Inhibition effect of triptolide on human epithelial ovarian cancer via adjusting cellular immunity and angiogenesis.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Cell Movement; Cell Proliferation; Diterpenes; Drug Resistance, Neoplasm; Epoxy Compounds; Female; Humans; Immunity, Cellular; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Glandular and Epithelial; Neovascularization, Pathologic; Ovarian Neoplasms; Phenanthrenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Inhibition of epithelial ovarian cancer by Minnelide, a water-soluble pro-drug.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carboplatin; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Cell Survival; Diterpenes; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Electric Impedance; Epoxy Compounds; Female; Humans; Mice; Mice, Nude; Neoplasms, Glandular and Epithelial; Organophosphates; Ovarian Neoplasms; Paclitaxel; Phenanthrenes; Prodrugs; Xenograft Model Antitumor Assays | 2014 |
Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cisplatin; Diterpenes; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Activation; Epoxy Compounds; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; JNK Mitogen-Activated Protein Kinases; Male; Neoplasms, Glandular and Epithelial; Phenanthrenes; Protein Binding; Protein Kinase C; Tumor Suppressor Protein p53 | 2008 |